Burns CM, Wortmann RL. Disorders of purine and pyrimidine metabolism. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. 19th ed. New York: Mc-Graw-Hill Education; 2016. p. 431e-1-6.
Johnson RJ, Rideout BA. Uric acid and diet--insights into the epidemic of cardiovascular disease. N Engl J Med 2004; 350: 1071-3.
Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76: 801-8.
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-41.
Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49: 298-303.
Grassi D, Ferri L, Desideri G, Di Giosia P, Cheli P, Del Pinto R, et al. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des 2013; 19: 2432-8.
Valbusa F, Bertolini L, Bonapace S, Zenari L, Zoppini G, Arcaro G, et al. Relation of elevated serum uric acid levels to incidence of atrial fibrillation in patients with type 2 diabetes mellitus. Am J Cardiol 2013; 112: 499-504.
Choi BG, Kim DJ, Baek MJ, Ryu YG, Kim SW, Lee MW, et al. Hyperuricaemia and development of type 2 diabetes mellitus in Asian population. Clin Exp Pharmacol Physiol 2018; 45: 499-506.
Juraschek SP, McAdams-Demarco M, Miller ER, Gelber AC, Maynard JW, Pankow JS, et al. Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol 2014; 179: 684-91.
Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 2012; 176: 108-16.
Elizalde-Barrera CI, Estrada-García T, Lozano-Nuevo JJ, Garro-Almendaro AK, López-Saucedo C, Rubio-Guerra AF. Serum uric acid levels are associated with homeostasis model assessment in obese nondiabetic patients:HOMA and uric acid. Ther Adv Endocrinol Metab 2017; 8: 141-6.
de Miranda JA, Almeida GG, Martins RI, Cunha MB, Belo VA, dos Santos JE, et al. The role of uric acid in the insulin resistance in children and adolescents with obesity. Rev Paul Pediatr 2015; 33: 431-6.
Lee SH, Kwon HS, Park YM, Ha HS, Jeong SH, Yang HK, et al. Predicting the development of diabetes using the product of triglycerides and glucose: the Chungju Metabolic Disease Cohort (CMC) study. PLoS One 2014; 9:e90430.
Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr 2014;61: 533-40.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6:299-304.
Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population:a hyperglycemic clamp validated study. Diabetes Res Clin Pract 2011; 93:e98-100.
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab 2010; 95: 3347-51.
Korea Centers for Disease Control and Prevention. The 7th Korean National Health and Nutrition Examination Survey [Internet]. Osong: KCDC;2016. [cited 2018 Jun].
Available from:
cdc.go.kr
Lee DY, Lee ES, Kim JH, Park SE, Park CY, Oh KW, et al. Predictive value of triglyceride glucose index for the risk of incident diabetes: a 4-Year Retrospective Longitudinal Study. PLoS One 2016; 11: e0163465.
Lee S, Kang ES, Lee KE, Jin H, Choi SH, Kim DJ, et al. Insulin resistance can predict the risk of metabolic syndrome. Korean J Med 2002; 63: 54-60.